DE3687071D1 - Malaria-impfstoff. - Google Patents

Malaria-impfstoff.

Info

Publication number
DE3687071D1
DE3687071D1 DE8686870013T DE3687071T DE3687071D1 DE 3687071 D1 DE3687071 D1 DE 3687071D1 DE 8686870013 T DE8686870013 T DE 8686870013T DE 3687071 T DE3687071 T DE 3687071T DE 3687071 D1 DE3687071 D1 DE 3687071D1
Authority
DE
Germany
Prior art keywords
malaria vaccine
malaria
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686870013T
Other languages
English (en)
Other versions
DE3687071T2 (de
Inventor
Mitchell Stuart Gross
James Francis Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE3687071D1 publication Critical patent/DE3687071D1/de
Application granted granted Critical
Publication of DE3687071T2 publication Critical patent/DE3687071T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE8686870013T 1985-02-07 1986-02-03 Malaria-impfstoff. Expired - Fee Related DE3687071T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69911585A 1985-02-07 1985-02-07

Publications (2)

Publication Number Publication Date
DE3687071D1 true DE3687071D1 (de) 1992-12-17
DE3687071T2 DE3687071T2 (de) 1993-03-25

Family

ID=24808000

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686870013T Expired - Fee Related DE3687071T2 (de) 1985-02-07 1986-02-03 Malaria-impfstoff.

Country Status (19)

Country Link
EP (1) EP0191748B1 (de)
JP (2) JPH0698005B2 (de)
CN (1) CN86100979A (de)
AP (1) AP17A (de)
AT (1) ATE82322T1 (de)
AU (1) AU603054B2 (de)
DE (1) DE3687071T2 (de)
DK (1) DK62486A (de)
EG (1) EG17878A (de)
ES (1) ES8704975A1 (de)
GR (1) GR860351B (de)
HU (1) HU201803B (de)
IL (1) IL77788A0 (de)
MY (1) MY102249A (de)
NZ (1) NZ215034A (de)
OA (1) OA08199A (de)
PT (1) PT81967B (de)
YU (1) YU18186A (de)
ZA (1) ZA86797B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192626B1 (de) * 1985-02-07 1992-07-29 Smithkline Beecham Corporation Malaria-Impfstoff
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0252588A3 (de) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Verfahren zur Isolierung und Reinigung von P. falciparum CS-Protein in rekombinantem E. coli sowie seine Verwendung als Impfstoff
EP0254862A1 (de) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Impfstoffe gegen protozoischen Parasiten
EP0293443B1 (de) * 1986-11-04 2003-02-26 Protein Polymer Technologies, Inc. Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
AP56A (en) * 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
JPH0222300A (ja) * 1987-02-02 1990-01-25 Swiss Serum & Vaccine Inst Bern 免疫原性接合体およびその製法ならびに免疫を生ぜしめる方法
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3787654D1 (de) * 1987-12-23 1993-11-04 Immuno Ag Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
CA2015722A1 (en) * 1989-05-03 1990-11-03 Mitchell S. Gross Malaria vaccine
CA2031468A1 (en) * 1989-12-08 1991-06-09 Mitchell S. Gross Malaria vaccine
CN105617375A (zh) 2009-05-05 2016-06-01 卡迪拉保健有限公司 麻疹-疟疾联合疫苗
US20180153945A1 (en) * 2016-12-05 2018-06-07 The United States Of America, As Represented By The Secretary Of Agriculture Oral e. coli vector-based vaccine for prevention of coccidiosis in poultry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Also Published As

Publication number Publication date
DK62486A (da) 1986-08-08
ES551656A0 (es) 1987-04-16
HU201803B (en) 1990-12-28
JPH0698005B2 (ja) 1994-12-07
GR860351B (en) 1986-06-05
MY102249A (en) 1992-05-15
ATE82322T1 (de) 1992-11-15
DK62486D0 (da) 1986-02-07
JPH07102150B2 (ja) 1995-11-08
AP8600020A0 (en) 1986-02-01
PT81967A (en) 1986-03-01
EG17878A (en) 1991-06-30
EP0191748B1 (de) 1992-11-11
EP0191748A1 (de) 1986-08-20
JPH07170995A (ja) 1995-07-11
AU5293686A (en) 1986-08-14
AU603054B2 (en) 1990-11-08
AP17A (en) 1988-04-02
PT81967B (pt) 1988-07-01
YU18186A (en) 1988-06-30
ZA86797B (en) 1986-09-24
HUT40917A (en) 1987-03-30
IL77788A0 (en) 1986-07-31
JPS61181387A (ja) 1986-08-14
NZ215034A (en) 1989-07-27
OA08199A (en) 1987-10-30
DE3687071T2 (de) 1993-03-25
CN86100979A (zh) 1986-12-17
ES8704975A1 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
DE3685833D1 (de) Dns-vakzine.
DE3650082T3 (de) Orale impfstoffe.
ATE77088T1 (de) 8-phenylxanthine.
DE3677710D1 (de) Cefuroximaxetil-dragee.
ATE55980T1 (de) 2-hydroxy-3-phenoxypropylamine.
DE3785404D1 (de) Impfstoffe.
DE3668776D1 (de) Endotubus.
DE3668381D1 (de) Contactlinse.
ATE50243T1 (de) Fluorbenzylester.
ATE82322T1 (de) Malaria-impfstoff.
ATE78869T1 (de) Malaria-impfstoff.
DE3676026D1 (de) Terpolymerisate.
DE3669772D1 (de) Russblaeser.
DE3677472D1 (de) Blockierverhinderer.
DE3786301D1 (de) Kombinierter impfstoff.
DE3673520D1 (de) Perfluorpolyaether.
DE3670979D1 (de) Raederfalzapparat.
DE3782960D1 (de) Impfstoffe.
FI86232B (fi) Oevervakningsanlaeggning.
DE3667938D1 (de) Raederfalzapparat.
DE3670767D1 (de) Rioprostil-pvp-komplex.
DE3670589D1 (de) Sandstrahlgeraet.
NO864764D0 (no) Vaksine.
NO901959L (no) Malaria-vaksine.
ATE59382T1 (de) Cyclohexanalkansaeuren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee